688553 匯宇製藥
按盤價 
17.460 -0.510 (-2.838%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -1.318 | 8.398 | 3.733 | 6.844 | 20.690 |
| 總資產報酬率 ROA (%) | -1.012 | 6.606 | 3.119 | 5.924 | 16.692 |
| 投入資產回報率 ROIC (%) | -1.131 | 7.341 | 3.471 | 6.657 | 19.866 | 邊際利潤分析 |
| 銷售毛利率 (%) | 80.491 | 83.414 | 85.929 | 88.202 | 91.375 |
| 營業利潤率 (%) | -10.423 | 31.838 | 13.415 | 15.767 | 26.251 |
| 息稅前利潤/營業總收入 (%) | -14.672 | 29.933 | 9.746 | 12.824 | 25.922 |
| 淨利潤/營業總收入 (%) | -7.424 | 28.865 | 15.029 | 16.674 | 24.448 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -73.671 | 25.107 | 40.379 | 79.263 | 92.377 |
| 價值變動淨收益/利潤總額(%) | 206.682 | 72.540 | 30.739 | 18.969 | 3.978 |
| 營業外收支淨額/利潤總額(%) | -1.343 | 0.362 | 5.892 | 1.235 | -0.221 | 償債能力分析 |
| 流動比率 (X) | 2.851 | 2.942 | 3.264 | 5.458 | 6.560 |
| 速動比率 (X) | 2.632 | 2.801 | 3.090 | 5.143 | 6.197 |
| 資產負債率 (%) | 23.692 | 23.080 | 19.447 | 13.058 | 13.828 |
| 帶息債務/全部投入資本 (%) | 12.712 | 12.782 | 10.295 | 1.708 | 0.768 |
| 股東權益/帶息債務 (%) | 672.900 | 672.970 | 863.990 | 5,704.069 | 12,635.091 |
| 股東權益/負債合計 (%) | 322.950 | 333.743 | 413.795 | 665.802 | 623.195 |
| 利息保障倍數 (X) | 3.344 | -14.809 | -2.161 | -4.083 | -95.398 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 24.384 | 18.070 | 19.179 | 6.594 | 2.472 |
| 存貨周轉天數 (天) | 369.534 | 310.428 | 440.314 | 352.322 | 312.971 |
| 備註： | 即時報價更新時間為 17/03/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
